LFCR

Dopo l'orario di chiusura: 4.86

Lifecore Biomedical Inc (LFCR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Lifecore Biomedical Inc

Healthcare (1100)

(952) 368-4300

3515 LYMAN BOULEVARD, CHASKA

Prossima data di guadagno

Ultimi documenti SEC

LFCR's Discussions on Twitter

Compare LFCR vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LFCR Lifecore Biomedical Inc	4.86	189.42M	147.12M	-33.88M	-13.62M	-0.4805
TAK Takeda Pharmaceutical Co Adr	16.96	53.37B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.84	42.80B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.65	41.09B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.29	31.62B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	563.70	23.23B	3.17B	1.29B	1.01B	27.09

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-17	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2025-09-04	Iniziato	KeyBanc Capital Markets	Sector Weight
2025-05-21	Iniziato	William Blair	Outperform
2024-09-05	Iniziato	Craig Hallum	Buy
2024-08-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2023-03-20	Downgrade	Stephens	Overweight → Equal-Weight

Mostra tutto

Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie

Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari

Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Compare LFCR vs TAK, HLN, TEVA, ZTS, UTHR

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie

Form 13D/A LIFECORE BIOMEDICAL For: 2 July By Investing.com - Investing.com India

Lifecore Biomedical faces $52.1M Series A preferred redemption due Dec. 28, 2026 - TradingView

Lifecore Biomedical (NASDAQ: LFCR) gets $52.1M preferred redemption requests - Stock Titan

[SCHEDULE 13D/A] LIFECORE BIOMEDICAL, INC. \DE\ Amended Major Shareholder Report - Stock Titan

(LFCR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations? - Yahoo Finance

Is Now An Opportune Moment To Examine Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - simplywall.st

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirt - The National Law Review

12 Best Low-Priced Pharma Stocks to Buy Right Now - Insider Monkey

Enterprise value to revenue forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Price to sales forward of Lifecore Biomedical, Inc. – SWB:LDE - TradingView

Price to book forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Price to sales forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView

Lifecore Biomedical, Inc. Actuals & Estimates (NASDAQ:LFCR) - TradingView

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biom - The National Law Review

Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView

Price to earnings forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView

Lifecore Biomedical, Inc. Actuals & Estimates (GETTEX:LDE) - TradingView

Lifecore Biomedical, Inc. Actuals & Estimates (BOATS:LFCR) - TradingView

LFCR Forecast — Price Target — Prediction for 2027 - TradingView

LDE Forecast — Price Target — Prediction for 2027 - TradingView

LFCR Q1 2026 Earnings: Wider-Than-Expected Loss Pressures SharesEnergy Earnings Report - dars.gov.et

How (LFCR) Movements Inform Risk Allocation Models - Stock Traders Daily

LFCR Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin, Stock Edges HigherAnnual Report - dars.gov.et

Lifecore Biomedical Inc (LFCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Lifecore Biomedical Inc (LFCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Lifecore Biomedical Inc (LFCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Lifecore Biomedical Inc (LFCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Lifecore Biomedical Inc (LFCR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Lifecore Biomedical Inc (LFCR) Institutional Confidence - TradingKey

Lifecore Biomedical Inc (LFCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Lifecore Biomedical Inc (LFCR) Valuation: PE, PB & Fair Value Analysis - TradingKey

Lifecore Biomedical Inc (LFCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Lifecore Biomedical signs manufacturing deal for neurology product By Investing.com - Investing.com Nigeria

Lifecore Biomedical signs manufacturing deal for neurology product - Investing.com

Lifecore Biomedical Signs Agreement for Tech Transfer and Commercial Production of Neurological Injectable Product - Quiver Quantitative

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company - GlobeNewswire

LFCR Q1 2026 Earnings: Wider-than-Expected Loss Weighs on Investor SentimentPreliminary Results - newsline.com

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - TMX Newsfile

Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook - Yahoo Finance

Trading Systems Reacting to (LFCR) Volatility - Stock Traders Daily

Lifecore Biomedical (LFCR) director awarded 25,907 RSUs - Stock Titan

Lifecore Biomedical (LFCR) director receives 25,907-share restricted stock award - Stock Titan

Lifecore Biomedical (LFCR) director receives 25,907 restricted stock units - Stock Titan

Lifecore Biomedical (LFCR) director receives 25,907-share restricted stock unit grant - Stock Titan

Lifecore Shareholders Approve New 2026 Stock Incentive Plan - TipRanks

Lifecore Biomedical (NASDAQ: LFCR) wins approval for 2026 stock plan - Stock Titan

LFCR Q1 2026 Earnings: EPS Misses Estimates Significantly, Stock Rises Despite WeaknessAnnual Financial Report - newsline.com

Lifecore Biomedical Signs Tech Transfer Agreement for Ophthalmic - Contract Pharma

Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a LFCR